124 related articles for article (PubMed ID: 26985708)
1. Curcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells.
Zhang Z; Chen H; Xu C; Song L; Huang L; Lai Y; Wang Y; Chen H; Gu D; Ren L; Yao Q
Oncol Rep; 2016 May; 35(5):2615-23. PubMed ID: 26985708
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.
Dong Y; Cao B; Zhang M; Han W; Herman JG; Fuks F; Zhao Y; Guo M
Oncotarget; 2015 Sep; 6(26):22126-38. PubMed ID: 26124080
[TBL] [Abstract][Full Text] [Related]
3. Correction to: Curcumin analog GO-Y030 inhibits tumor metastasis and glycolysis.
J Biochem; 2024 Feb; 175(2):215. PubMed ID: 37982668
[No Abstract] [Full Text] [Related]
4. Curcumin inhibits intracellular fatty acid synthase and induces apoptosis in human breast cancer MDA-MB-231 cells.
Fan H; Liang Y; Jiang B; Li X; Xun H; Sun J; He W; Lau HT; Ma X
Oncol Rep; 2016 May; 35(5):2651-6. PubMed ID: 26985864
[TBL] [Abstract][Full Text] [Related]
5. Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.
Hou TY; Davidson LA; Kim E; Fan YY; Fuentes NR; Triff K; Chapkin RS
Annu Rev Nutr; 2016 Jul; 36():543-70. PubMed ID: 27431370
[TBL] [Abstract][Full Text] [Related]
6. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.
Yan C; Sun W; Wang X; Long J; Liu X; Feng Z; Liu J
Mol Nutr Food Res; 2016 May; 60(5):1139-49. PubMed ID: 26989875
[TBL] [Abstract][Full Text] [Related]
7. Interferon γ-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines.
Shan J; Oshima T; Wu L; Fukui H; Watari J; Miwa H
PLoS One; 2016; 11(3):e0151701. PubMed ID: 26986625
[TBL] [Abstract][Full Text] [Related]
8. Critical involvement of the α(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia.
Che Y; Ren X; Xu L; Ding X; Zhang X; Sun X
Oncol Rep; 2016 May; 35(5):3025-33. PubMed ID: 26986216
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
10. Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer.
Li B; Chen P; Chang Y; Qi J; Fu H; Guo H
Biochem Biophys Res Commun; 2016 Sep; 478(2):739-45. PubMed ID: 27498032
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Sensitizes Silymarin to Exert Synergistic Anticancer Activity in Colon Cancer Cells.
Montgomery A; Adeyeni T; San K; Heuertz RM; Ezekiel UR
J Cancer; 2016; 7(10):1250-7. PubMed ID: 27390600
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen.
Gallardo M; Calaf GM
Int J Oncol; 2016 Jun; 48(6):2534-42. PubMed ID: 27082017
[TBL] [Abstract][Full Text] [Related]
13. Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress.
Lu Y; Zhang R; Zhang X; Zhang B; Yao Q
Biomed Pharmacother; 2020 Sep; 129():110381. PubMed ID: 32887024
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and Colorectal Cancer: From Basic to Clinical Evidences.
Pricci M; Girardi B; Giorgio F; Losurdo G; Ierardi E; Di Leo A
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235371
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Disrupts a Positive Feedback Loop between ADMSCs and Cancer Cells in the Breast Tumor Microenvironment via the CXCL12/CXCR4 Axis.
Jang BY; Shin MK; Han DH; Sung JS
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004606
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.
Sadeghi M; Dehnavi S; Asadirad A; Xu S; Majeed M; Jamialahmadi T; Johnston TP; Sahebkar A
Inflammopharmacology; 2023 Jun; 31(3):1069-1093. PubMed ID: 36997729
[TBL] [Abstract][Full Text] [Related]
18. A systems biology investigation of curcumin potency against TGF-β-induced EMT signaling in lung cancer.
Kandagalla S; Sharath BS; Sherapura A; Grishina M; Potemkin V; Lee J; Ramaswamy G; Prabhakar BT; Hanumanthappa M
3 Biotech; 2022 Nov; 12(11):306. PubMed ID: 36276461
[TBL] [Abstract][Full Text] [Related]
19. Curcumin against gastrointestinal cancer: A review of the pharmacological mechanisms underlying its antitumor activity.
Fan Y; Zhang X; Tong Y; Chen S; Liang J
Front Pharmacol; 2022; 13():990475. PubMed ID: 36120367
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches to colorectal cancer
Chen M; Lin W; Li N; Wang Q; Zhu S; Zeng A; Song L
Front Microbiol; 2022; 13():945533. PubMed ID: 35992678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
